Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies curetoday 0:45 8 years ago 1 182 Скачать Далее
Shaji Kumar, MD, provides perspective on the role of anti-CD38 antibodies changing multiple myeloma OBRoncology 0:45 4 years ago 23 Скачать Далее
Phase I study of TNB-383B in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:30 2 years ago 193 Скачать Далее
Why Don't They Mention Monoclonal Antibody Side Effects? David Pakman Show 5:02 2 years ago 81 314 Скачать Далее
HealthTree Podcast for Myeloma: Shaji Kumar, MD, Mayo Clinic on ETBs in Myeloma HealthTree Foundation for Multiple Myeloma 50:52 5 months ago 20 Скачать Далее
Advances in Multiple Myeloma, Dr. Shaji Kumar, Mayo Clinic USA امراض الدم Saudi Blood 27:04 4 years ago 156 Скачать Далее
Shaji Kumar, MD, discusses excitement about bispecific antibodies in multiple myeloma OBRoncology 3:08 4 years ago 96 Скачать Далее
Dr. Kumar on Future Treatment Landscape of Multiple Myeloma OncLive 1:32 7 years ago 115 Скачать Далее
Dr. Kumar on Takeaways From the ENDURANCE Trial in Multiple Myeloma OncLive 1:45 4 years ago 68 Скачать Далее
Shaji Kumar on Recent Clinical Trial Developments in Myeloma DocWire 2:50 2 years ago 156 Скачать Далее
Shaji Kumar, ASCO20: Efficacy and Toxicity in the Randomised Phase III ENDURANCE Trial in Myeloma Touch Medical Media 7:04 4 years ago 141 Скачать Далее
Shaji Kumar, MD, explains how immunotherapies are being integrated into treatment algorithms for MM OBRoncology 1:11 7 years ago 27 Скачать Далее
Monoclonal antibody therapies: what healthcare providers need to know. National Institutes of Health (NIH) 2:34 3 years ago 2 810 Скачать Далее
Lummicar-2: CT053 for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:39 3 years ago 88 Скачать Далее
FDA revokes authorization for last remaining monoclonal antibody treatment Click On Detroit | Local 4 | WDIV 2:00 1 year ago 1 077 Скачать Далее
